Imax price target lowered to $44 from $46 at Roth Capital

Roth Capital lowered the firm’s price target on Imax (IMAX) to $44 from $46 and keeps a Buy rating on the shares. The company’s box office in North America and International, ex-China showed impressive Q1 growth while coming up against tough China comparisons that ultimately proved too large of a headwind to overcome, the analyst tells investors in a research note. Roth adds that it likes the movie lineup spread out over the rest of 2026, especially in the back half of the year, and anticipates further market share expansion for Imax.